Skip to content
OpenCapital
Get started

Globus Medical GMED Debt Securities, Available-for-sale, Amortized Cost, Noncurrent

Debt Securities, Available-for-sale, Amortized Cost, Noncurrent at other companies

Wells Fargo & Company logo
Wells Fargo & CompanyWFC
$156.64B+6.0%
Wintrust Financial logo
Wintrust FinancialWTFC
$52.66M-14.6%
Stifel Financial logo
Stifel FinancialSF
$25.99M-74.8%
Paychex logo
PaychexPAYX
$0-100%
BK
BKBK
$107.65B+9.8%
Popular logo
PopularBPOP
——

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0×0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's debt securities, available-for-sale, amortized cost, noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's debt securities, available-for-sale, amortized cost, noncurrent?
Globus Medical (GMED) reported debt securities, available-for-sale, amortized cost, noncurrent of $170.22M in Q1 2026.
What is the long-term trend for Globus Medical's debt securities, available-for-sale, amortized cost, noncurrent?
Over 4 years (2021 to 2025), Globus Medical's debt securities, available-for-sale, amortized cost, noncurrent has grown at a -40.3% compound annual growth rate (CAGR), from $564.36M to $71.68M.